A Study to Assess the Safety, Tolerability and Efficacy of ION775

Clinical trial NCT07604974 · RECRUITING

Trial details

NCT number: NCT07604974
Sponsor: Ionis Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertriglyceridemia Severe Hypertriglyceridemia

Start date: 2026-05-12
Primary completion: 2027-09-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.